Pertussis in Soldiers, Israel by Klement, Eyal et al.
LETTERS
trophoresis. Patterns were compared
visually with reference patterns (6). 
From January 1, 2003, to March
31, 2004, a total of 44 of 124 male
rectal swabs were positive for C. tra-
chomatis. Of those, 38 were identified
as belonging to the L2 serotype,
which confirms the diagnosis of rectal
LGV. Epidemiologic information was
retrospectively obtained by clinicians
through review of medical records,
telephone interview, or both. A com-
plete history was available for 14 of
the 38 cases. All 14 men reported
unprotected anal sex with anonymous
male sex partners in France, and none
reported a stay in an LGV-endemic
area. Their mean age was 40 years
(31–50); 8 were HIV-infected, and 9
had another concomitant STD. The
mean duration of symptoms before
LGV diagnosis was 50 days (range
11–120 days). All 14 patients had
symptoms of acute proctitis, including
rectal pain, discharge, and tenesmus,
and 3 (all HIV-infected) had fever.
Deep, extended rectal ulcerations
were reported in 8 patients, 3 of
whom were HIV-infected and had
lesions suggestive of rectal carcino-
ma. In 1 patient in whom a late diag-
nosis was made 4 months after the
onset of symptoms, a rectal tumorlike
stricture was observed. All 14 patients
were treated with tetracycline for a
mean duration of 16 days (range
10–60 days).
An information campaign among
microbiologists and clinicians and a
sentinel LGV surveillance system
were launched in April 2004.
Subsequently, LGV was diagnosed in
65 additional male patients, some ret-
rospectively. In total, rectal LGV was
diagnosed in 103 patients from July
2002 to August 2004 (Figure).
Prompt diagnosis and treatment is
indeed paramount to prevention and
control. Diagnosis may be further
hampered because rectal LGV may
mimic other conditions such as rectal
carcinoma or Crohn disease.
Treatment duration should be no
shorter than 21 days, and follow-up
examinations should be conducted
until all signs and symptoms have
resolved (7,8). If left untreated, rectal
LGV could lead to serious complica-
tions such as rectal stricture (1). If
recently exposed to infection, sexual
contacts should receive prophylactic
treatment to prevent reinfection and to
eliminate a potential reservoir. The
emergence of rectal LGV, character-
ized by deep mucosal ulcerations and
frequently occurring in HIV-infected
men who have sex with men, is a seri-
ous concern for the gay community in
Europe. 
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Pertussis in
Soldiers, Israel
To the Editor: The role of adults
as reservoirs of pertussis was previ-
ously well established (1–7). Young
army recruits undergoing basic train-
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Figure. Number of rectal lymphogranuloma venereum cases diagnosed in men in France,
July 2002–August 2004.LETTERS
ing in the Israeli Defense Force con-
stitute a unique adult population
because of their special living and
service conditions. This and the fact
that they are not vaccinated with the
diphtheria, tetanus, and pertussis
(DTP) vaccine after the age of 1 year
(unlike children in most of the
Western countries) led us to hypothe-
size that this semiclosed population
may have an exceptionally high risk
for pertussis. These young soldiers are
on leave on weekends, during which
time they come in close contact with
susceptible family members, includ-
ing young infants, and may thus facil-
itate the “import” and “export” of per-
tussis between the military setting and
the general population. An outbreak
of pertussis that recently occurred
among infantry soldiers (8) indicated
the need to conduct the present study,
in which we sought to evaluate the
prevalence and incidence of pertussis
among young soldiers in the Israeli
Defense Force.
We conducted 2 concurrent stud-
ies. The first was a 15-month
(November 2001–March 2003), labo-
ratory-based surveillance study of
pertussis, which included 110 trainees
who complained of persistent cough-
ing (case definition: cough lasting
10–90 days) upon admission to com-
pound clinics. Samples obtained from
these patients were tested by a com-
mercial enzyme-linked immunosor-
bent assay (ELISA) (PanBio, East
Brisbane, Queensland, Australia) for
the presence of immunoglobulin (Ig)
A against a Bordetella pertussis soni-
cate and by an in-house IgA-detection
ELISA directed against pertussis
toxin as previously described (9).
Results for IgA to B. pertussis soni-
cate were calculated as arbitrary
ELISAunits obtained according to the
manufacturer’s instructions. A result
of 9 U (a cutoff point that was previ-
ously shown to provide a 98.5%
specificity for the diagnosis of recent
pertussis infection ([8]) or higher was
considered positive. Results for IgAto
pertussis toxin were calculated as
arbitrary ELISA units according to a
calibration curve of a serially, double-
diluted, positive standard. The cutoff
point was calculated by adding 3 stan-
dard deviations to the mean value of a
group of 40 healthy study partici-
pants. A positive result in either test
was considered a confirmed case of
pertussis.
We conducted another substudy to
estimate incidence. This substudy
included 278 trainees who were inter-
viewed regarding the occurrence of
persistent cough and seeking of med-
ical care during the preceding 6
months. We multiplied the prevalence
of laboratory-confirmed pertussis
found in the first study by the inci-
dence of study participants with per-
sistent cough who sought medical
care in this study. The result was mul-
tiplied by 200,000 to receive inci-
dence estimation for 100,000 person-
years. 
The median duration of cough
among the 110 case-patients was 14
days, their median age was 19 years,
94 (85.5%, 95% confidence interval
[CI] 77.5%–91.5%) were males, 71
(64.5%, 95% CI 54.9%–73.4%) were
born in Israel, and 85 (77.3%, 95% CI
68.3%–84.7%) were in basic training
when they visited the clinic. Twenty
(18.2%, 95% CI 11.5%–26.7%) and
14 (12.7%, 95% CI 7.1%–20.4%) of
the patients were positive for IgAanti-
bodies to B. pertussis and pertussis
toxin, respectively. Twenty-five
patients (22.7%, 95% CI
15.3%–39.7%) were positive by
either test. Significant variations were
recorded during the follow-up period.
The first period (November
2001–May 2002) was characterized
by a high prevalence of pertussis
among the 72 patients enrolled, with
19 (26.4%, 95% CI 16.7%–38.1%)
and 14 (19.4%, 95% CI
11.1%–30.5%) positive for IgA to B.
pertussis and pertussis toxin, respec-
tively. In the second period (August
2002–March 2003), although charac-
terized by the same median duration
of cough (14 days), a substantially
lower prevalence of pertussis was
observed among the 38 patients
enrolled, with only 1 (2.6%) and 0
patients, respectively, showing posi-
tive results in either of the 2 tests (p <
0.01 for differences between the 2
periods for both diagnostic methods). 
The frequency of clinical symp-
toms observed in patients positive for
pertussis by at least 1 ELISA (n = 25)
was similar to those observed in
patients negative for pertussis by both
ELISAs (n = 85), with the exception
of post-tussive emesis (40% versus
25%, respectively) and fever (4% ver-
sus 21%). These differences were not
significant. 
Of the 278 basic training respon-
dents, 17 (6.1%, 95% CI 3.6–9.6%)
reported a persistent cough (>2
weeks) during the preceding 6-month
period; 13 (4.7%, 95% CI
2.5%–7.9%) had sought medical care.
When we extrapolated from this sam-
ple and from the laboratory-con-
firmed prevalence of 22.7% among
patients with persistent coughing who
sought medical care (and thus came to
the clinics), the incidence rate was
2,132 cases per 100,000 person-years
(95% CI 440–6,240).
The prevalence of pertussis found
in this study is comparable with that
previously reported among U.S.
Marine corps trainees, university stu-
dents, and other civilian adult popula-
tions (1–7). Complete case-capturing
could not be performed. However, the
high clinical similarity between per-
tussis-positive and other cases of pro-
longed cough renders selection bias
unlikely. The prevalence of disease in
this study showed significant changes
in relation to time in contrast to previ-
ous studies (3). This difference may
be because our present study was con-
ducted in a semiclosed population
characterized by epidemic occurrence
of the disease. 
The incidence of pertussis reported
in this study (2,132 cases per 100,000
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person-years) is substantially higher
than the findings of Nennig and others
(10) among an urban population in
San Francisco (176 cases per 100,000
person-years).  This finding may be
due to the difference in immunization
practices between Israel and the
United States (5 doses of DTPvaccine
in the United States with the last 1
administered between the ages of 4
and 6 years, compared with only 4
doses of the vaccine during the first
year of life in Israel) or to crowded
living conditions of the recruits. Our
findings emphasize the need for
revaccination against pertussis of
young adults in Israel, primarily of
those at high risk for pertussis, such as
army recruits.
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Food Safety for
First Responders 
To the Editor: Relatively few
published reports of intentional food
contamination are available (1–5).
However, after the anthrax attacks of
2001, biologic terrorism vulnerability
assessments have determined that
intentional food poisoning is a plausi-
ble means to widely disseminate
pathogens, with potentially devastat-
ing effect (6). As a consequence, food
security has emerged as one of the
major priorities for bioterrorism pre-
paredness (7–10). We describe a natu-
rally occurring incident that demon-
strates the potential for premeditated
food contamination to target specific
populations who are critical for pro-
tecting public safety, in this instance,
a city police force. Measures to miti-
gate the risk of this scenario type are
provided.
On the evening of December 19,
1998, local hospital emergency
departments notified the Hawaii
Department of Health that an unusual-
ly high number of police officers were
coming to the hospitals with acute
gastroenteritis. Earlier that day, sever-
al police-affiliated support associa-
tions had cosponsored a holiday
event. The food was catered by a food
service establishment that routinely
provided meals at the police depart-
ment headquarters in Honolulu.
Active and retired police officers and
their family members participated in
the event. The food service at the
event consisted of “bento lunch
boxes” containing luncheon meat, a
hot dog, teriyaki beef, fried chicken,
and rice. Approximately 1,100 lunch-
es were distributed at the event, some
of which were taken offsite to be con-
sumed by others, including on-duty
officers at satellite police stations. 
Interviews were conducted with a
convenience sample of 394 persons
who ate the bento lunch, of which 145
(37%) reported becoming ill with
diarrhea (81%) or vomiting (80%).
Illness onset occurred a mean of 4
hours after eating the lunch (1.5–8
hours); the mean duration of illness
was 14 hours (2–96 hours).
Incapacitation of police officers and
their family members as a result of the
illness was substantial with 25%
absent from work for a half day, 42%
for 1 full day, 18% for 2 days, and
15% for more than 2 days.
Staphylococcus aureus was recovered
from 7 of 8 stool specimens, of which
6 were positive on S. aureus toxin
testing. Analyses of the lunch items
found between 18 million to 3 billion
S. aureus colonies per gram in the
implicated foods. Luncheon meat,
teriyaki beef, and hot dogs were posi-
tive on S. aureus toxin assays. S.
aureus isolates obtained from food
and clinical specimens were indistin-
guishable by pulsed field-gel elec-
trophoresis. The quantity of lunch
boxes produced for this holiday event
exceeded that which the catering
facility routinely produced while
adhering to recommended food-han-